Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Processa Pharmaceuticals Inc (PCSA)

Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Processa Pharmaceuticals Inc 601 21ST STREET SUITE 300 VERO BEACH FL 32960 USA

www.processapharmaceuticals.com Employees: 10 P: 772-453-2899 F: 443-288-4420

Sector:

Medical

Description:

Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,837
Enterprise Value, $K 7,647
Shares Outstanding, K 2,266
Annual Sales, $ 0 K
Annual Net Income, $ -11,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,440 K
EBIT, $ -13,020 K
EBITDA, $ -13,020 K
60-Month Beta 1.09
% of Insider Shareholders 2.40%
% of Institutional Shareholders 91.93%
Float, K 2,211
% Float 97.60%
Short Interest 5,434
Short Float 0.00%
Short Volume Ratio 0.57

Growth:

1-Year Return -84.17%
3-Year Return -99.36%
5-Year Return -99.89%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 72.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/06/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.36
EPS Growth vs. Prev Qtr 72.00%
EPS Growth vs. Prev Year 93.20%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 12/17/25

PCSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -301.42%
Return-on-Assets % -217.32%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.31
Book Value/Share 0.12
Interest Coverage -1.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar